This R21 grant application is submitted in response to Innovative Research Grant Program Announcement (PA-06-239) for analyses of existing clinical databases with newer parameters or methodologies. Recent investigations have found that statin therapy is associated with a lower risk of ventricular arrhythmias and cardiac mortality including sudden cardiac death. However, the mechanisms are not well understood. The Vascular Basis for Treatment of Myocardial Ischemia Study, a randomized, double- blind, controlled trial, recently reported in stable coronary artery disease (CAD) patients that statin therapy was associated with reduction in ischemic episodes and duration of ischemia compared with pretreatment baseline. Autonomic and cardiac electrophysiologic effects remain to be evaluated. We propose to employ newly developed noninvasive ambulatory-ECGs (AECG) indices to assess baroreceptor reflexes (by heart rate turbulence (HRT) analysis), autonomic tone (by heart rate variability (HRV) analysis), and cardiac electrical instability (by T-wave alternans (TWA) analysis) to evaluate effects of intensive as compared with moderate statin therapy on autonomic and cardiac electrophysiologic factors in 300 patients in Vascular Basis trial.
SPECIFIC AIMS : 1) To determine whether intensive statin therapy with atorvastatin to a target LDL of 80 mg/dL with or without supplemental antioxidant vitamins C and E improves autonomic tone (HRV) and reflexes (HRT) in patients with stable CAD, compared with moderate statin therapy with diet and low- dose lovastatin as needed to reach an LDL goal of 130 mg/dL. 2) To quantify the effects of intensive versus moderate statin therapy on cardiac electrical instability as measured by TWA magnitude. At the time of AECG monitoring, patients were free of antiischemic and antiarrhythmic medications. Our analysis would constitute the largest investigation of effects of statins on autonomic tone and reflexes and on cardiac electrophysiologic function. This proposal will examine the effects of intensive as compared with moderate statin therapy on autonomic function and cardiac electrophysiologic function using newly developed noninvasive ambulatory-ECGs (AECG) indices in patients enrolled in the Vascular Basis trial. Ultimately, the present proposal could provide novel insights into mechanisms whereby statin therapy may reduce risk for life-threatening arrhythmias and thereby impact the major public health problem of sudden cardiac death. ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Exploratory/Developmental Grants (R21)
Project #
1R21HL085720-01A1
Application #
7254342
Study Section
Clinical and Integrative Cardiovascular Sciences Study Section (CICS)
Program Officer
Lathrop, David A
Project Start
2007-04-20
Project End
2009-03-31
Budget Start
2007-04-20
Budget End
2008-03-31
Support Year
1
Fiscal Year
2007
Total Cost
$224,497
Indirect Cost
Name
Beth Israel Deaconess Medical Center
Department
Type
DUNS #
071723621
City
Boston
State
MA
Country
United States
Zip Code
02215
Nearing, Bruce D; Wellenius, Gregory A; Mittleman, Murray A et al. (2012) Crescendo in depolarization and repolarization heterogeneity heralds development of ventricular tachycardia in hospitalized patients with decompensated heart failure. Circ Arrhythm Electrophysiol 5:84-90
Verrier, Richard L; Nieminen, Tuomo (2010) T-wave alternans as a therapeutic marker for antiarrhythmic agents. J Cardiovasc Pharmacol 55:544-54
Verrier, Richard L; Kumar, Kapil; Nearing, Bruce D (2009) Basis for sudden cardiac death prediction by T-wave alternans from an integrative physiology perspective. Heart Rhythm 6:416-22
Verrier, Richard L; Josephson, Mark E (2009) Impact of sleep on arrhythmogenesis. Circ Arrhythm Electrophysiol 2:450-9
Verrier, Richard L; Tan, Alex (2009) Heart rate, autonomic markers, and cardiac mortality. Heart Rhythm 6:S68-75